These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34734168)

  • 21. The Safety of Irreversible Electroporation on Nerves Adjacent to Treated Tumors.
    Luo X; Qin Z; Tao H; Shi J; Fang G; Li Z; Zhou X; Chen J; Xu K; Zeng J; Niu L
    World Neurosurg; 2017 Dec; 108():642-649. PubMed ID: 28927918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
    Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
    Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.
    Deodhar A; Monette S; Single GW; Hamilton WC; Thornton R; Maybody M; Coleman JA; Solomon SB
    Urology; 2011 Mar; 77(3):754-60. PubMed ID: 21111458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological effect of irreversible electroporation on hepatocellular carcinoma.
    Guo X; Du F; Liu Q; Guo Y; Wang Q; Huang W; Wang Z; Ding X; Wu Z
    BMC Cancer; 2021 Apr; 21(1):443. PubMed ID: 33882892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
    Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
    J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer.
    He C; Huang X; Zhang Y; Lin X; Li S
    Clin Transl Med; 2020 Jun; 10(2):e39. PubMed ID: 32508058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency.
    Ueshima E; Schattner M; Mendelsohn R; Gerdes H; Monette S; Takaki H; Durack JC; Solomon SB; Srimathveeravalli G
    Gastrointest Endosc; 2018 Jan; 87(1):300.e1-300.e6. PubMed ID: 28501593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Chronologic Change in the Size and Contrast-Enhancement of Ablation Zones on CT Images after Irreversible Electroporation and Radiofrequency Ablation.
    Scheck J; Bruners P; Schindler D; Kuhl C; Isfort P
    Korean J Radiol; 2018; 19(4):560-567. PubMed ID: 29962862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Irreversible Electroporation on the Femur: Experimental Study in a Rabbit Model.
    Song Y; Zheng J; Yan M; Ding W; Xu K; Fan Q; Li Z
    Sci Rep; 2015 Dec; 5():18187. PubMed ID: 26655843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Immunologic Response of Irreversible Electroporation versus Cryoablation in a Rodent Model of Pancreatic Cancer.
    White SB; Zhang Z; Chen J; Gogineni VR; Larson AC
    J Vasc Interv Radiol; 2018 Dec; 29(12):1764-1769. PubMed ID: 30316676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible electroporation of the uterine cervix in a rabbit model.
    Chai W; Zhang W; Wei Z; Xu Y; Shi J; Luo X; Zeng J; Cui M; Li J; Niu L
    Biomed Microdevices; 2017 Nov; 19(4):103. PubMed ID: 29138988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible electroporation of the liver and liver hilum in swine.
    Charpentier KP; Wolf F; Noble L; Winn B; Resnick M; Dupuy DE
    HPB (Oxford); 2011 Mar; 13(3):168-73. PubMed ID: 21309933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of irreversible electroporation on femoral nerves in a rabbit model.
    Kwon JH; Kim MD; Kim SH; Lee EW; Kahlid SA
    Minim Invasive Ther Allied Technol; 2022 Feb; 31(2):306-312. PubMed ID: 32744129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.
    Lee EW; Chen C; Prieto VE; Dry SM; Loh CT; Kee ST
    Radiology; 2010 May; 255(2):426-33. PubMed ID: 20413755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.